Recent advances in mesothelioma
ثبت نشده
چکیده
patients with malignant bowel obstruction (MBO). J Pain Symptom Manage 1994;9: 12–18. 11 Ketcham AS, Hoye RC, Pilch YH, Morton DL. Delayed intestinal obstruction following treatment for cancer. Cancer 1970;25:406–10. 12 Weiss SM, Skibber JM, Rosato FE. Bowel obstruction in cancer patients: performance status as a predictor of survival. J Surg Oncol 1984;25:15–17. 13 Chan A, Woodruff RK. Intestinal obstruction in patients with widespread intraabdominal malignancy J Pain Symptom Manage 1992;7:339–42. 14 Feuer DJ, Broadley KE, Shepherd JH, Barton DP. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Review. Cochrane Database Syst Rev 2000; no 4:CD002764. www.cochrane.org/cochrane/revabstr/ab0
منابع مشابه
Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment
Pleural malignancies constitute either primary pleural malignancies, such as malignant pleural mesothelioma (MPM), or secondary pleural tumours, either from pleural metastasis or direct extension of adjacent tumours. Mesothelioma is a rare aggressive tumour of the pleural surfaces associated with prior asbestos exposure. Mesothelioma is also a challenging disease from a diagnostic staging, and ...
متن کاملChanging Pattern in Malignant Mesothelioma Survival
UNLABELLED Survival for mesothelioma has been shown to be poor, with marginal improvement over time. Recent advances in the understanding of pathophysiology and treatment of mesothelioma may impact therapy to improve survival that may not be evident from available clinical trials that are often small and not randomized. Therapies may affect survival differently based on mesothelioma location (p...
متن کاملMalignant pleural mesothelioma: from the bench to the bedside.
Optimal management of malignant pleural mesothelioma (MPM), which is mainly based on patient characteristics and clinical stage, is not clearly defined yet, although detailed, practical guidelines for these patients have been proposed by some scientific societies. Translational research, in the field of this disease, is currently in progress and different molecular oncogenic pathways leading to...
متن کاملTargeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma
Malignant mesothelioma is an aggressive and often fatal cancer associated with asbestos exposure. The disease originates in the mesothelial lining of the serosal cavities, most commonly affecting the pleura. Survival rates are low as diagnosis often occurs at an advanced stage and current treatments are limited. Identifying new diagnostic and therapeutic targets for mesothelioma remains a prior...
متن کاملTechnological Advances in the Treatment of Cancer: Combining Modalities to Optimize Outcomes.
The anticancer treatment modality tumor treating fields (TTFields; Optune, Novocure) use the lower frequency range of the electromagnetic spectrum to destroy tumor cells during mitosis. This treatment has been evaluated in several trials of patients with glioblastoma. In these patients, TTFields are delivered through 4 transducer arrays applied to the scalp. In a phase 3 clinical trial of patie...
متن کاملNew strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.
Malignant pleural mesothelioma (MPM) is a highly lethal cancer with limited therapeutic options. Recent work has focused on the frequent somatic inactivation of two tumor suppressor genes in MPM-NF2 (Neurofibromatosis type 2) and the recently identified BAP1 (BRCA associated protein 1). In addition, germline mutations in BAP1 have been identified that define a new familial cancer syndrome, whic...
متن کامل